Healthspan podcast

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

7/10/2024
0:00
11:00
Retroceder 15 segundos
Avanzar 15 segundos

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

Otros episodios de "Healthspan"